About Manisha Chatterjee
Since she was young, Manisha has had a strong interest in the stock market. She majored in Economics in college and has a passion for writing, which has led to her career as a research analyst.
Manisha’s goal is to help individual investors succeed in the stock market. She uses her knowledge in fundamental analysis to evaluate companies and determine if they are worthwhile investments.
Recent Articles By Manisha Chatterjee
Is Synchronoss Technologies a Good Software Stock to Buy?
Investors reacted positively to software company Synchronoss Technologies’ (SNCR) $100 million stock offering on June 25. It plans to use the offering’s proceeds primarily to redeem preferred stock and pay down its revolving credit facility. However, because SNCR is facing intense competition from top players in the software space, the question is, is it wise to bet on the stock now? Let’s find out.
Is Vipshop Holdings a Buy Under $20?
China-based online discount retailer Vipshop (VIPS) has achieved decent growth over the past few years. However, increasing regulatory pressure has diminished investors’ attention in the stock over the past several months. So, having declined 29.4% so far this year, can the stock’s price rebound in the near-term. Let’s discuss.
Is Brookfield Renewable Partners a Good Renewable Energy Stock to Invest in?
As one of the top players in the renewable energy space, Brookfield Renewable (BEP) is expected to benefit from the favorable policy measures adopted by governments worldwide and increasing investment in the renewable energy space. However, is it wise to buy the units now despite BEP’s high valuation? Read on to learn more.
Is Atomera a Good Chip Stock to Buy Now?
Shares of semiconductor materials and technology licensing company Atomera (ATOM) have gained 53% year-to-date on investor optimism surrounding the delivery of its MST IP transfer package earlier this year in accordance with a joint development agreement. But is the stock’s valuation in sync with its near-term growth prospects and thus an attractive buy? Let’s find out.
Is DraftKings a Buy Under $50?
The share price of Sports entertainment and gaming company DraftKings (DKNG) has declined 3.9% since Hindenburg Research revealed its short position in the stock on June 15. So, can the stock gain based on Redditors’ interest in it and on its numerous strategic alliances? Let’s discuss and find out.
Is Orphazyme a Winner in the Biotech Industry?
Shares of Denmark-based biopharmaceutical company Orphazyme’s (ORPH) experienced extreme volatility this month due to the actions of retail traders that were triggered by discussions about the stock on social media platforms such as Reddit. After hitting its $4.75 all-time low on June 2, this meme stock soared to hit its $77.77 all-time high on June 10. The stock has gained 28.6% over the past month, but let’s find out if it has upside remaining given the FDA’s rejection of its Niemann-Pick treatment. Read on.
Up 64% in the Past Month, Will Li Auto Continue to Rally?
Chinese EV-maker Li Auto (LI) garnered significant investor attention over the past month launching 2021 Li ONE in May 2021. The stock has soared 63.8% over this period. However, can it keep rallying despite the global semiconductor shortage? Let’s find out.
Airbnb vs. Choice Hotels International: Which Stock is a Better Buy?
The hotel industry received a severe blow last year as several hotels had to be closed due to the COVID-19 pandemic-related restrictions. However, with solid progress on the vaccination front, the industry’s prospects look better this year. After being restricted for more than a year, people are venturing out of their homes this summer. So, both Airbnb (ABNB) and Choice Hotels International (CHH) might witness a solid recovery this year. But let’s find out which of these two stocks is a better buy now.
Is Galecto a Winner in the Biotech Industry?
Denmark-based biotechnology company Galecto (GLTO) has been making some progress on developing treatments for diseases such as fibrosis and cancer. The stock has gained 18.7% over the past month. But can it keep ascending? Let’s find out.